Brief: Onxeo H1 net loss stable at 11.6 million euros
July 28 (Reuters) - ONXEO SA C4X.PA :
* H1 REVENUE EUR 3.4 MILLION VERSUS EUR 1.9 MILLION YEAR
AGO
* H1 OPERATING LOSS EUR 11.3 MILLION VERSUS LOSS OF 11.2
MILLION YEAR AGO
* AT JUNE 30, 2017, THE COMPANY HAD CONSOLIDATED CASH
POSITION OF 27.7 MILLION
* H1 NET LOSS EUR 11.6 MILLION VERSUS LOSS OF EUR 11.2
MILLION YEAR AGO
Source text: http://bit.ly/2veLn3Q
Further company coverage: C4X.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Valerio Therapeutics SA
See all newsBrief: Valerio Therapeutics To Buy Etherna Immunotherapies For €30 Mln
Brief: Valerio Therapeutics Signs Development Collaboration With Abivax
Brief: Valerio Therapeutics Enters Into Collaboration & Exclusive License With Seed-Stage Biotech Co
Brief: Onxeo Changes Its Name And Becomes Valerio Therapeutics
Brief: Onxeo H1 Net Loss Widens To EUR 11.5 Mln